Key regions: China, Europe, Australia, United States, Germany
The Other Pharmaceuticals market in Sudan has been experiencing significant growth in recent years.
Customer preferences: Customers in Sudan have been increasingly demanding pharmaceutical products that are affordable and of high quality. This has led to a rise in the demand for Other Pharmaceuticals in the country, as they are generally more affordable than brand-name drugs. Additionally, with the rise of chronic diseases in the country, there has been an increased demand for medications that can help manage these conditions.
Trends in the market: One trend that has been observed in the Other Pharmaceuticals market in Sudan is the increasing availability of generic drugs. This has been driven by the government's efforts to promote the use of generic drugs in the country, as they are generally more affordable than brand-name drugs. Another trend that has been observed is the increasing use of e-commerce platforms to purchase pharmaceutical products. This has made it easier for customers to access the products they need, particularly those living in rural areas.
Local special circumstances: Sudan is a country that has been affected by political instability and economic challenges in recent years. This has had an impact on the pharmaceutical industry, particularly in terms of the availability of products. Additionally, the country has a large rural population, which can make it difficult for customers to access pharmaceutical products.
Underlying macroeconomic factors: The growth of the Other Pharmaceuticals market in Sudan can be attributed to several underlying macroeconomic factors. These include the country's growing population, rising disposable incomes, and increasing healthcare expenditure. Additionally, the government's efforts to promote the use of generic drugs in the country have also contributed to the growth of the market. However, challenges such as political instability and economic challenges continue to pose a risk to the growth of the market in the country.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
